Japan Chemical, which is based in Tokyo, is reportedly in the final stages of a deal to supply US troops with a chemical used to treat nerve gas in Syria, Reuters reports.
The company, which was reportedly worth $50 billion, will reportedly be selling its stock on the Tokyo Stock Exchange, the agency says.
The sale is expected to close by March 2020, the report adds.
The US military has been using a variety of chemical agents to treat soldiers in Syria.
The chemical agent, known as sarin, is a potent nerve agent.
The US military says it has used it to neutralize nerve gas released by Syrian government forces in the country’s civil war.